Molecular Tumor Board: 68 year-old male with metastatic right-sided colon adenocarcinoma with KRAS A146V and MET exon 14 mutations

Case review of a 68-year-old male with metastatic right-sided colon adenocarcinoma with KRAS A146V mutation. Frontline biomarker testing with OmniSeq INSIGHT provided initial options for therapy, but when his tumor progressed rapidly, Labcorp Plasma Focus liquid biopsy helped his oncologist determine next line of therapy.

Presented by: 

Heidi Ko, DO - Labcorp Oncology, Director, Medical Affairs

Kyle Strickland, MD, PhD - Labcorp Oncology, Director, Medical Affairs